Christopher H. Van Dyck, Site 039

Yale University School of MedicineNew Haven, Connecticut - 06519 (203-974-7043) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

A Multicenter Double Blind Placebo-Controlled Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
May 2009 - December 2012
Alzheimer Disease
Placebo
Bms-708163



